Pharma

Events

Partner Content

4th RAS-Targeted Drug Development Summit

For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible.

Digital

Top 5 takeaways from international hybrid and virtual meetin...

The move to online international meetings has left pharma companies with uncertainty around contact compliance.

Partner Content

Partner Content

[Webinar] Patient Centricity Drives Action: Research Support...

Research Supports the Value of Social Health

Partner Content

Partner Content

KOL Validation: An Opportunity To Benchmark Mindset

The benefits of conducting a regular KOL validation exercise to refresh your KOL list are well established.

News

AbbVie and Cugene partner to tackle autoimmune diseases

AbbVie and Cugene have teamed up to research autoimmune diseases and cancer in an exclusive worldwide agreement.

Views & Analysis

Do pharmaceutical businesses need to rethink what their grad...

As the world and the UK continues its march out of the pandemic’s shadow, the pharmaceutical and life sciences sector has been squarely in the spotlight.

4th RAS-Targeted Drug Development Summit

Top 5 takeaways from international hybrid and virtual meetin...

[Webinar] Patient Centricity Drives Action: Research Support...

KOL Validation: An Opportunity To Benchmark Mindset

AbbVie and Cugene partner to tackle autoimmune diseases

Do pharmaceutical businesses need to rethink what their grad...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Pharma

Editor's Picks